What does this research mean for the field?

Hypertension, overweight or obesity, kidney disease, and uterine fibroids are significantly associated with the comorbidity of thyroid and breast diseases in women aged 25–55 years. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Identify clinical and metabolic factors associated with the co-occurrence of thyroid and breast diseases in adult women.

September 2, 2026International Journal of Women s HealthOpen Access

Clinical and Metabolic Factors Associated with Comorbidities of Thyroid and Breast Diseases in Women Aged 25–55 Years

View Full Paper

Ask AI

Bookmark

Authors

JHJiuying HuBengbu Medical College YDYu DingAnhui Medical University JWJuan WuNanjing University of Chinese Medicine

Discussion

Member takes

Overview

Observational study reveals metabolic and clinical factors linked to combined thyroid and breast conditions in young to middle-aged women, highlighting key targets for integrated screening.

Key Points

Identify clinical and metabolic factors associated with the co-occurrence of thyroid and breast diseases in adult women.
Conducted a secondary analysis of physical examination data from 17,086 women aged 25–55 years at a tertiary hospital in China.
Compared demographic, clinical, and metabolic variables among women without thyroid or breast disease, those with a single disease, and those with thyroid-breast comorbidity.
Nearly half of the cohort presented with comorbidities, showing significant differences across groups for age, BMI, hypertension, diabetes, uterine fibroids, lung disease, liver disease, and kidney disease (all P < 0.05).
Thyroid-breast comorbidity was independently associated with uterine fibroids (OR = 2.542, 95% CI: 1.879–3.439), overweight or obesity (OR = 1.472, 95% CI: 1.211–1.788), hypertension (OR = 1.434, 95% CI: 1.063–1.934), and kidney disease (OR = 1.424, 95% CI: 1.161–1.747).

Cite This Study

Hu et al. (2026) studied this question.

synapsesocial.com/papers/6a97e275c562ede874ec6a3f https://doi.org/10.2147/ijwh.s613820

View Full Paper

Ask AI

Bookmark

September 2, 2026International Journal of Women s HealthOpen Access

Clinical and Metabolic Factors Associated with Comorbidities of Thyroid and Breast Diseases in Women Aged 25–55 Years

View Full Paper

Ask AI

Bookmark

Authors

JHJiuying HuBengbu Medical College YDYu DingAnhui Medical University JWJuan WuNanjing University of Chinese Medicine

Discussion

Member takes

Overview

Observational study reveals metabolic and clinical factors linked to combined thyroid and breast conditions in young to middle-aged women, highlighting key targets for integrated screening.

Key Points

Identify clinical and metabolic factors associated with the co-occurrence of thyroid and breast diseases in adult women.
Conducted a secondary analysis of physical examination data from 17,086 women aged 25–55 years at a tertiary hospital in China.
Compared demographic, clinical, and metabolic variables among women without thyroid or breast disease, those with a single disease, and those with thyroid-breast comorbidity.
Nearly half of the cohort presented with comorbidities, showing significant differences across groups for age, BMI, hypertension, diabetes, uterine fibroids, lung disease, liver disease, and kidney disease (all P < 0.05).
Thyroid-breast comorbidity was independently associated with uterine fibroids (OR = 2.542, 95% CI: 1.879–3.439), overweight or obesity (OR = 1.472, 95% CI: 1.211–1.788), hypertension (OR = 1.434, 95% CI: 1.063–1.934), and kidney disease (OR = 1.424, 95% CI: 1.161–1.747).

Cite This Study

Hu et al. (2026) studied this question.

synapsesocial.com/papers/6a97e275c562ede874ec6a3f https://doi.org/10.2147/ijwh.s613820

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark